Best Doctors in Italy — Get an Online Consultation

In 1995 he graduated at the Faculty of Medicine and Surgery form the Catanzaro University “Magna Graecia”, where, in 2001, he specialized in Internal Medicine. In 2006 he attended the “State of the Art in AFIB and HF Treatments” course directed by Dr. Carlo Pappone. In 2014 he attended the Heart Rhythm Management Center Universitair Ziekenhuis in Brussel and obtained the certification for the procedures for the treatment of atrial fibrillation using cryoenergy (Cryoballon Training Program). In 2015, he was certified for MICRA-TPS leadless pacemaker implantation procedures at Medtronic Training Center in Minneapolis (MICRA-TPS Training Program).

Dr Iacopino is a member of important national and international scientific societies such as the American College of Cardiology, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association and the European Society of Cardiology. He directs several study projects, applicable to great benefit for the patient on the identification of rare syndromes associated with arrhythmias and heart failure, such as Brugada syndrome, or Wolff-Parkinson-White syndrome. He recently tested, for the first time in Italy, the CardioInsight, an innovative hi-tech jacket for 3D mapping of the heart rhythm disturbances. He has participated and hosted numerous medical conferences around the world, providing theoretical and practical preparation for the various interventional procedures aimed at electrophysiologists and electrophysiology technicians from all over Italy and abroad (United Kingdom, Germany, Spain, Russia). He was a member of the AIAC National Electrophysiology and Ablation Registry, the AIAC Lead Extraction National Registry and the AIAC Pacemaker and Implantable Defibrillator National Registry.

He is author or co-author of several publications and interventions in prestigious medical journals (total impact factor: 169.098).

He has been awarded different fellowships: 

- Fellowship ANMCO (National Association of Hospital Cardiologists), Florence, 3 June 2007; 

- Fellowship ESC (European Society of Cardiology), Munich, 1 September 2008; 

- Fellowship ACC (American College of Cardiology), Atlanta, February 1, 2010

Since 2007 he has been Coordinator of the Operative Unit of Orthopedics and Traumatology at Maria Cecilia Hospital and Scientific Supervisor of the Orthopedic Area of GVM Care & Research, where every year more than 1,200 cases are treated by his team of orthopedists.

He operates in the field of diagnosis and therapeutic treatment of degenerative diseases and traumatic diseases of the knee, hip, shoulder, ankle, foot, hand, spine; in the arthroscopic treatment of the wrist, hip, knee and shoulder and in major prosthetic surgery for the knee, hip, shoulder, as well as in orthopedic and physiatric rehabilitation. In particular, he specializes in the treatment of the following pathologies: femoro-acetabular impingement, pubalgia, chondropathy, Perthes disease, synovitis and the snapping hip syndrome. Author of 7 monographs of over 100 publications in national scientific journals. Among the most recent publications: "Thirty years of Arthroscopy in Italy" 2011 Argalia Publishing and "Groin Pain Syndrome" 2017 Publishing Springer-Verlag. He is the author of over 200 reports on Hip, Knee, Ankle, Shoulder Prosthetics, Hip, Ankle, Knee, Elbow, Wrist, Shoulder Arthroscopy, BioTechnology, Sports Traumatology. He was awarded twice with the Bellando-Randone Prize of the Italian Society of Orthopedics and Traumatologists (SIOT) for the best monograph of the year 1983 with the book "Radiculography Lombare - Text Atlas", Editrice Roma; and for the best monograph of the 1997 with the volume "Arthroscopy of the ankle - Practical manual of surgical technique" Editrice Fortuna.

Dr. Borghesi leads the Neurosurgery Unit at Maria Cecilia Hospital, where his team performs around 1,000 advanced neurosurgical procedures annually. His approach combines years of experience with the latest technological innovations to ensure patients receive the most effective treatments available. Specializing in spinal surgeries (including cervical, dorsal, and lumbar procedures), Dr. Borghesi utilizes both posterior and anterior techniques to help patients regain mobility and relieve pain. Throughout his career, he has successfully performed over 4,500 complex surgeries, offering life-changing solutions for patients with challenging cranial and spinal conditions.

For brain tumor removal, he and his team employ advanced video-micro-surgical techniques, including the use of a digital microscope with 4K 3D imaging, which allows for enhanced precision and minimal invasiveness. Patients suffering from conditions like trigeminal neuralgia, facial spasms, and tumors of the posterior cranial fossa can benefit from Dr. Borghesi’s expertise in minimally invasive surgery, having treated over 400 cases with innovative techniques.

• Spinal Surgery: Expert in performing complex spinal surgeries (cervical, thoracic, and lumbar) using the latest methods to treat conditions such as herniated discs, spinal degeneration, and more.
• Brain Tumor Removal: Specializes in minimally invasive brain surgery for the removal of extensive tumors using cutting-edge 3D orbital camera technology.
• Trigeminal Neuralgia: Successfully treated over 400 cases of trigeminal neuralgia and other cranial nerve disorders with minimally invasive techniques, providing relief for patients with less recovery time.
• Colloid Cyst Removal: The doctor specializes in complex surgeries to remove this benign but very rare tumor.

Dr. Borghesi has trained in various top-tier international hospitals, learning from the best to provide high-quality care to his patients:

• Spinal Unit at Schulthess Klinik in Zurich
• École de Chirurgie in Paris, specializing in skull base and spinal surgeries
• Brain Institute at the University of Florida, specializing in microsurgical brain procedures
• Microsurgical Laboratory at the University of Arkansas, with a focus on lumbar degenerative disorders

He is the author of numerous scientific publications in national and international journals and volumes. In 1997 he was consultant of the "Medical Review" Journal.

Dr. Motti works at the Neurosurgery Department at Maria Cecilia Hospital, as the coordinator of the Gamma Knife Operating Unit, and neurosurgeon in charge of the Stereotaxic Neurosurgery Unit, one of the few centers in Italy, which specializes in the Gamma Knife treatments.  

He is an active member of several research companies focused on Gamma Knife: Italian Society of Neurosurgery, Rome; Gamma Knife Society, Stockholm; European Gamma Knife Society, Madrid. In 1982 he obtained the patent for interfacing the Talairach stereotaxic helmet with computerized axial tomography methods. In 1987 he made the first brain implantation of rgic cells in Parkinson's disease in Italy. He is responsible for training courses at national and international levels, such as courses in Stereotaxic Techniques, Functional Neurosurgery, Radiosurgery at the School of Specialization in Neurosurgery, by the University of Milan; He was an Invited speaker at the "Compliance in radiosurgery" course at the GKSociety meeting in Seoul, South Korea; Organizer of the First European Meeting of Gamma Knife Users, in 1996 in Milan and its subsequent editions.

He is often invited as an instructor in the first weeks of the opening of the new Gamma Knife centers, such as from the Hospital of the University of California Davis, Sacramento, California; or the Arsenji Hospital in Bucharest, Romania etc.

Author and co-author of about 100 publications and contributors to national and international journals. In the seventies he contributed as Assistant Editor to the editorial board of the Journal of Neurosurgical Sciences. For twenty years he was a Consultant in medical libraries as an expert in research techniques and bibliographic archives.

Professor Carlo Selmi is leading the Rheumatology and Clinical Immunology Unit at Humanitas Research Hospital. 

Since 2009, he is the responsible of the Autoimmunity and Metabolic Laboratory, dedicated to the study of the possible mechanism linked to the progression of autoimmune diseases. 

The research focuses on four main areas: 

• - The epigenetic mechanisms that regulate the environment-genomic interface by influencing the susceptibility and the phenotype of chronic autoimmune and inflammatory diseases in the model of discordant monozygotic twins for disease. To date, the laboratory has biological sample of discordant couples for numerous diseases.
• - The target antigens of autoimmunity modifications that affect the development of the course of autoimmune diseases. In particular, the laboratory studies the post-translational modifications of joint collagen in rheumatoid arthritis.
• - The prevalence of non-organ autoantibodies, such as anti-nucleus and anti-ENAs and disease specific autoantibodies, such as anti-citrulline and anti-endomysium in a non-specific population of health adults and the significance of the positive founds over time.
• - Gender medicine in real-life, through the analysis of administrative databases.

The team holds dedicated clinics also for, spondiloarthritis and connetcive tissue disease, and it is active in articular ultrasound, videocapillaroscopy, arthrocenthesis and joint injection of steroid or hyaluronic acid.  The Division includes an inpatient clinic for complex cases. All group members are fluent in spoken and written English

Current Teaching Activity: Professor Selmi works as Assistant Professor of Rheumatology at the University of Milan since 2006. Furthermore, he holds a joint appointment as Assistant Professor of Medicine at the Division of Rheumatology of the University of California at Davis since 2005.

He is member of the American College of Rheumatology, American Association of Allergists and Immunologists, and the Italian Society of Rheumatology. He serves on the International Group for Research on Psoriatic Disease (GRAPPA) and the working group for autoantibody standardization within the ACR (ASC).

Publications: Selmi C[Author] - Search Results - PubMed (nih.gov)

Professor Santoro is heavily involved in research, with interest in many topics, such as the development of new cancer drugs and new biological therapies, interests for solid and haematological tumours, and not only he treats cancer survivors but also patients with comorbidities.

He has worked in Humanitas Research Hospital for 22 years. Professor Santoro’s post-graduate research was carried out at the Unité de Development Therapeutique (Institut de Cancerologie et d’Immunogenetique, Villejuif of Paris) from 1974 to 1975, and in the Division of Medical Oncology of the National Cancer Institute of Milan from 1976 to 1977. 

In 1977, he specialized in Clinical and Laboratory Haematology at University of Rome. In 1979, he completed his fellowship post-graduate work in the Memorial Sloan Kettering Cancer Center of New York and later, at Stanford University. In 1980, he specialized in oncology at the University of Genoa. 

Current Teaching Activity: Professor Santoro worked as Contract Professor at the Specialization School in Clinical Pathology ad Pavia University from 1992 to 1997. Also, from 1993 to 2002 he has been President of the Rare Tumour Group. Now he is full professor at Humanitas University. 

Current Positions: 

• .Since 1997, he is the Director of the Department of Medical Oncology and Haematology, at Istituto Clinico Humanitas, Milan. Also, he is Member of the Ethics Committee of Istituto Clinico Humanitas and Director of Clinical Research in the same Institute since 2007.
• - Since 2008, he is Member of the Planning Committee, Ministry of Work and of Health and Social Politics, Rome, Italy.
• - Since October 2008, Professor Santoro is Counsellor of the Board of Directors of the Fondazione Humanitas for Research of Rozzano, Italy.
• - Since November 2008, he is Expert Member of the National Centre for the Prevention and Control of Disease, Ministry of Work and of Health and Social Politics (Rome, Italy).
• - Since February 2009, he is National Representative preparatory actions for the "European Partnership for Action against Cancer" Ministry of Work and of Health and Social Politics (Rome, Italy).
• - Since February 2009, Professor Santoro is member of National Italian Committee on the Research Network in Oncology, Ministry of Work and of Health and Social Politics (Rome, Italy).
• - Since May 2009, he is Coordinator of the Oesophageal-Stomach Cancer Group Coordinator of the Liver and Biliary Tree Cancer Group, Regional Oncology Commission – Lombardy Oncology Network.

In addition, Professor Santoro’s unique expertise was recognized through numerous awards, such as the Managing Doctor of the Year award (2013), the City of Siena S. Caterina d’Oro Award (2013, Serra Association Award for scientific research) and social and healthcare commitment (Salerno, 2009). 

Publications: santoro%a - Search Results - PubMed (nih.gov) 

Prof. Alessandro Repici is the Director of the Gastroenterology and Digestive endoscopy Unit in Humanitas Research Hospital. Graduated in Medicine and Surgery in 1990 and the following year he won a scholarship at the Department of Gastroenterology Molinette hospital in Turin, where he began his practice in digestive endoscopy. In 1992, he worked with Prof. Claude Liguory as a fellow at the American Hospital in Paris.

In 1994 he became a specialist in Gastroenterology and Digestive Endoscopy at the University of Messina and worked in the Department of Gastroenterology, Ospedale Maggiore Molinette of Turin.

In the following years, he has been working at the Service of Digestive Endoscopy of Altona Hospital in Hamburg, directed by prof. Hagenmuller, and in the Department of Gastroenterology Molinette Hospital in Turin, directed by prof. Rizzetto. In 1999, he was a Research Fellow at the Center for Oncological and Operative Endoscopy of Wellsley Hospital in Toronto.

He teaches Gastroenterology and Digestive Endoscopy at the School of Specialization in Oncology since 2000, at the University of Turin since 2004 and Endoscopy Diagnostic Techniques and Operations at the School of Specialization in General Surgery I and II of the University of Turin.

The clinical activity and research of Prof. Repici mainly focuses on the development of new endoscopic techniques in the field of diagnosis and therapy, with particular attention to new methods of endoscopic removal of cancerous lesions and early in the palliation of advanced gastrointestinal malignancies.

Prof. Repici is coordinator, principal investigator and co-investigator in more than 50 studies, including phase II and III for FDA and EMA approval of new molecules and new instruments for diagnostic and operational endoscopy. 

Prof. Repici collaborates on research projects in the field of endoscopy with the University of Rotterdam, in Haifa, in New York and with several Italian centers. He is a member of various national and international scientific society of Gastroenterology and Digestive Endoscopy.

Publications: http://www.ncbi.nlm.nih.gov/pubmed/?term=repici+alessandro

Dr. Daniela Pini is the Head of the Cardio-respiratory rehabilitation Unit.

Medical areas of interest: Dr. Daniela Pini has been working and researching heart failure and has gained considerable experience in the management of advanced forms of this pathology. She is also very interested in the evaluation and "overall" management of patients suffering from this disease, which mainly affects elderly people and who already have other chronic diseases, which, if neglected, can easily impair the effectiveness of treatment for heart failure itself.

Research areas of interest: new therapies for advanced heart failure: replacement therapy of the heart with mechanical assistance devices to the circulation or heart transplant. New drugs and devices. Multidisciplinary patient management programs.

Further information of interest: thanks to the high competence of cardiosurgeons, electrophysiologists and hemodynamists, Humanitas can count, as a clinical cardiologist, on a team that allows it to offer the patient all the range of therapeutic options for heart failure.

From June 2000 to October 2001 she was Visiting Assistant Professor at the Cardiovascular Division Hospital of the University of Pennsylvania. During this period, she worked in the Heart Failure/Heart Transplantation Program, where she participated in the management of patients with advanced heart failure waiting for transplantation, dealing in particular with medical complications in patients with mechanical assistance devices. She has also worked with kidney, kidney-pancreas, pancreas-insulae, lung, liver and heart transplant teams, dealing with the multiple aspects of managing solid organ transplant recipients.

She worked in the Niguarda Ca' Granda Hospital, at the Cardiomyopathy and Heart Transplantation Service, dealing mainly with patients with advanced heart failure and undergoing a cardiac transplant.

Dr. Pini is a member of the coordination committee of the Decompensation Area of the National Association of Medical Hospital Cardiologists – ANMCO. In the last two years she has been mainly concerned on building a network of “heart failure clinics” on the national territory.

Dr. Federico Pessina is the Cranial Neurosurgey Unit Director.

Medical areas of interest: Brain tumors, glioblastomas, low grade gliomas, brain metastases, meningiomas, neuromas, cavernous angiomas, brain aneurysms

Surgical treatment with brain mapping techniques, awake and minimally invasive surgery of all central nervous system tumors.

Surgical treatment of highly complex tumors of the skull base and cranio-cervical hinge: meningiomas, neuromas, craniopharyngiomas, brain stem tumors.

All the tumor pathologies described above are addressed after multidisciplinary multi-specialist evaluation.

The surgical approach is customized to the patient and to the type of lesion, making use of the most advanced intraoperative techniques for malignant brain tumors (neuronavigation, intraoperative neurophysiology, intraoperative CT) and more complex approaches (anterior, posterior and combined petroosectomies, minimally invasive accesses) for benign diseases of the skull base such as meningiomas and neuromas.

Research areas of interest: Experimental protocols in the treatment of glioblastomas

- Prospective protocols in the treatment of brain metastases

- Role of surgical removal and integrated treatments in glioblastomas and malignant brain tumors

- Intracranial meningiomas

- Cadaver lab dissection

Author of more than 60 scientific publications and 5 book chapters, he is member of Italian Society of Neurosurgery (SINCH).

In 2018 he joined the Scientific Committee of European Society of Neuroncology (EANO) and the Skull Base Surgery Committee of World Federation of Neurosurgical Society (WFNS).

Specialized training: 

Prof. Pessina obtained his Degree in Medicine and Surgery in University of  Insubria,  Varese, where he also completed his Residency Program.

From 2007 to 2008 he covered the role of Clinical Fellow in Neurosurgery in Lausanne University Hospital, focusing on image-guided intrinsic brain tumors resection and vascular neurosurgery

In 2018 he covered the Skull Base fellow position in Lariboisiere Hospital, Paris, fully dedicating to skull base surgery and hands-on dissection practice and teaching.

Since 2022, he is Full Professor in Neurosurgery (MED/27) in Humanitas University

Additional information of interest:

Member of the Scientific Committee of the European Association of Neuroncology (EANO)

Publications:  https://www.ncbi.nlm.nih.gov/pubmed/?term=Pessina+Federico

Dr. Lucia Torracca is leading the Cardiac Surgery Unit at Humanitas Research Hospital. She received her training at Ospedali Civili di Brescia and at Ospedale San Raffaele with Professor Ottavio Alfieri, were she improved her knowledge in the mitral disease focusing in the reparative and preservative approaches. At the same institution she led the minimal invasive and robotic division before moving to Ospedali Riuniti Di Ancona to be chief of the Cardiac Surgery Complex Unit. Dr. Torracca has performed more than 55 hundred cardiac surgeries. Thanks to her surgical and academic curriculum, she has been an active member of the steering committee of the European Society editing Guidelines for the treatment of heart diseases.

Together with her team in Humanitas, she can approach every cardiac disease affecting adults, especially focusing on the minimal invasive approach to reparative valve disease. State of the art technologies are regularly explored and implemented in the Open Heart dedicated Operating Room and Intensive Care Unit to ensure best outcomes, shorter hospital stay and fewer surgical complications.

The surgical expertise of Dr. Torracca go from open heart circulatory-arrest procedure to off-pump and/or trans-catheter procedures (MitraClip or TransApical Aortic Valve Implants).

Dr. Torracca and her team can claim the highest rate of mitral valve repair in Bi-leaflet prolapse (Barlow Disease) hitting almost 99% of conservative approach in minimal invasiveness at the time of surgery, maintaining >95% success rate at long term follow up: this option is further advantageous in the youngest patient population allowing restrain from anticoagulation therapy and perfectly normal quality of life.

Author or co-author of 151 publications in national and international scientific journals.

Prof. Nicola Portinaro is the Director of the Orthopaedic Paediatric and neuro-orthopaedic Unit at Humanitas Research Hospital, and is Professor of Orthopaedics and Traumatology at the University of Milan. 

He was appointed as Fellow of the Royal College of Surgeons, Edinburgh, and from 2000 until now, Honorary Special Senior Lecturer at University of Bristol, UK. Founder and Scientific Director of "Ariel Foundation", a non profit foundation for pediatric neurological disabilities founded in 2002. 

The team of Professor Portinaro is one of the internationally recognized leading teams in the field of paediatric orthopaedics and neuro-orthopaedic surgery with an experience of over 100 bone surgerical procedures on lower limb every year, including 50 pelvic osteotomies and more than 300 surgical procedures on muscles and tendons (lightening, transfer…). He is specialized in the treatment of lower and upper limb deformities related to Cerebral Palsy, Spina Brifida, Developmental Dysplasia of the Hip, Perthes Disease, clubfoot and alteration in skeletal development. 

A considerable part of his activity is in scientific research, with several experimental works with the goal of detecting uknown anchors aspects of diseases treated by him. His research fields include the study of genomic and proteomic of extracellular matrix proteins in different diseases. 

Publications: http://www.ncbi.nlm.nih.gov/pubmed/?term=portinaro 

Prof. Alberto Albanese is the Neurology Unit Director at Humanitas Research Hospital. Until recently – Department Head of Neuroscience at the Institute of Neurology Carlo Besta (Milan). In 1977 prof. Albanese received his degree in medicine and surgery, in 1981 – in neurology, and in 1985 – in psychiatry. His professional experience began with the founding of the Department of “disorders of Parkinson’s and violations of the musculoskeletal system” at the clinic “A. Gemelli “in Rome in 1984, which he led until 1996. From 1996 to 2000 prof. Albanese was the Head of the Neurological University Clinic of Lausanne (Switzerland) and a professor of Neurology in the University.

From 2000 to 2015 he was Head of Neuroscience Department at the Institute of Neurology Carlo Besta (Milan).

Prof. Albanese is a professor of neurology at the Institute of Neurology at the Catholic University of the Sacred Heart (Milan), Director of the post-graduate course “Diagnosis and treatment of movement disorders and degenerative neurological diseases” at the Foundation Neurological Institute “C. Besta”, as well as an adjunct professor at the School of Specialization in Neuroscience at the University of Milan Bicocca.

Prof. Albanese is the president of “Italian Association of Parkinson’s disease and movement disorders” and “Italian Association for the Study of the autonomic nervous system” (which are part of “Italian Community of Neuroscience”). He is also an honorary member of the “French Community of Neuroscience.” The professor is a moderator and speaker at major national and international neurological conferences, he organized several symposia dedicated to Neurology, collaborates with numerous national and international research centers, which are studying Parkinson’s disease, movement disorders and degenerative neurological diseases. Prof. Albanese has been repeatedly receiving research fundings from the following government agencies: the Ministry of Health, Ministry of Science and Research, National Research Council, the British Council, the Swiss National Research Council.

He is one of the greatest Italian experts on the diagnosis and treatment of neurological diseases and movement disorders, Parkinson.

He has extensive experience in the use of neurostimulation of brain neurological movement disorders, for treating Parkinson’s disease and other involuntary movements.

He developed the first Italian project on the study of genetic disease and Parkinson’s dystonia, which led to the discovery of two new genetic loci. Also prof. Albanese is actively engaged in research in the field of semiotics detailed definition of involuntary movements, which allows tracking of related clinical pathology for accurate diagnosis of patients with movement disorders.

Prof. Albanese has published more than 200 scientific papers, most of which are published in indexed journals (with a total impact factor>500), is the author of one monograph, 3 books and co-author of numerous books and publications. He is the chief editor of “Frontiers in Movement Disorders” and assistant editor of the “European Journal of Neuroscience”.

Publications: http://www.ncbi.nlm.nih.gov/pubmed?term=albanese a

Prof. Alessandro Castagna is the Orthopedic Surgery of the Shoulder and Elbow Unit Director in Humanitas Research Hospital. He performs both traditional surgeries and arthroscopic surgeries. He developed experience in arthroscopic surgery of the shoulder in the United States where he studied at the Southern California Orthopedic Institute, under the guidance of Dr. Stephen J. Snyder (famous shoulder surgeon, inventor and co-developer of surgical tools for shoulder arthroscopy).

Prof. Castagna gained experience in open surgery of the shoulder under the guidance of Prof. Mario Randelli, founder and past-president of the Italian Society for Surgery of the Shoulder, in Milan (Italy). He has specialized almost exclusively in shoulder surgery for more than 25 years and counts over 40.000 cases in his career. He carries out about 900 surgeries per year, including total shoulder prostheses, reverse prostheses, open and arthroscopic stabilization, rotator cuff repair and proximal humerus fractures.

Research areas of interest: 

Improvement of surgical and therapeutic methods of shoulder pathology. He gives particular attention to the study of biological and functional aspects with the development of surgical techniques, materials and dedicated tools. 

Teaching experience: Adjunct Professor at the Orthopedics Course of Specialization in Diseases of the Locomotor System at the University of L'Aquila.

Scientific activity: 

Prof. Castagna was president of European Society for Surgery of the Shoulder and the Elbow (ESSSE/SECEC) (www.secec.org) from 2012 to 2014 and president of Italian Society for Surgery of the Shoulder and Elbow (SICS&G) (www.sicseg.it) from 2010 to 2012. He is also a Member of the Board di International Congress of Shoulder and Elbow Surgery (ICSES, www.icses.org) nominated for the period from 2013 to 2022.

Publications: http://www.ncbi.nlm.nih.gov/pubmed/?term=castagna+alessandro

Prof. Alessio Michele Goffredo Aghemo is the Hepatology Unit Director in Humanitas research Hospital.

Medical areas of interest: 

• liver diseases
• viral hepatitis
• metabolic hepatitis
• liver cirrhosis

Previous experience: 

From 2007 to 2017 he was the 1st level Medical Director at the U.O of Gastroenterology of the IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Milan.

Research areas of interest: 

Clinical and research activity focused on natural history and treatment of viral hepatitis.

He is the author of 155 peer-reviewed publications (Impact Factor total 1151.3, H-Index 25 according to Scopus, H-Index 20 last 5 years Scopus, H-Index 30 according to Google Scholar) (updated September 2017).

From 2013 to 2016 he was a scientific member of the governing board of the European Association for the Study of the Liver (EASL).

Since 2016 he is a member of the scientific committee of the European Association of Gastroenterology (UEG).

He is a member of the AISF (Italian Association for the Study of the Liver) commission for antiviral drugs directed against HCV (2012-present). Since 2016 he has been the coordinator of the same. 

He was AIFA/EMEA expert for liver disease since 2008.

Member of the Executive Committee of the HCV Regional Network, determined by the Lombardy Region on 28 September 2015.

He participated as an expert in the drafting of the European Guidelines 2013-2014-2015-2016-2017 (EASL) and Italian (AISF) on the Treatment of Chronic Hepatitis C.

Teaching experience:

He is associated professor of Gastroenterology at Humanitas University since September 2017.

Prof. Arturo Chiti graduated in Medicine and Surgery at the University of Milan in 1989, and in the same year he entered the Post graduated School in Nuclear Medicine at the University of Milan, where he got his degree in 1993. In the same year he started working as Associate Chief at the National Cancer Institute in Milan, where he began his clinic and scientific experience in Oncology.
In 1997, he got the European Board of Nuclear Medicine fellowship.

In June 2000 he started leading the Nuclear Medicine Department at Humanitas Research Hospital.

On March 1, 2015 he was appointed Full Professor in Diagnostic Imaging and Radiotherapy at the Humanitas University in Milan, where he is also elected member of the Board.

Prof. Chiti is the Unit Director of the Nuclear Medicine Unit in Humanitas Research Hospital. He is the Director of the Post Graduate School in Diagnostic Imaging at Humanitas University. He is member of the Technical and Scientific Committee of the National Centre for Oncologic Adrotherapy (CNAO).

Arturo Chiti is co-author of several papers (www.scopus.com, www.pubmed.com) with an H-index of 30 (July 2016), wrote some books’ chapters and contributed to many abstracts presented at international and national meetings.
He is Honorary Editor of the European Journal of Nuclear Medicine and Molecular Imaging and reviewer for several international journals and grant applications.

He is a well-known invited speaker at numerous international congresses and conferences.

Prof. Arturo Chiti is the President of the European Association of Nuclear Medicine (EANM), where he has been active for more than 10 years.

He is also acting as an expert consultant for International Atomic Energy Agency (IAEA) and is member of the International Commission on Radiation Units and Measurements (ICRU).

He was awarded the honorary membership of the European Society for Therapeutic Radiology and Oncology (ESTRO); the Tom Miller Memorial Lecture Award from the Society of Nuclear Medicine and Molecular Imaging and the Hevesy Gyorgy award from the Hungarian Society of Nuclear Medicine.

Publications:

https://www.ncbi.nlm.nih.gov/pubmed/?term=chiti+arturo